1. Home
  2. RAPT vs EP Comparison

RAPT vs EP Comparison

Compare RAPT & EP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • EP
  • Stock Information
  • Founded
  • RAPT 2015
  • EP 1983
  • Country
  • RAPT United States
  • EP United States
  • Employees
  • RAPT N/A
  • EP N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • EP Oil & Gas Production
  • Sector
  • RAPT Health Care
  • EP Energy
  • Exchange
  • RAPT Nasdaq
  • EP Nasdaq
  • Market Cap
  • RAPT 117.5M
  • EP 131.5M
  • IPO Year
  • RAPT 2019
  • EP N/A
  • Fundamental
  • Price
  • RAPT $0.94
  • EP $4.85
  • Analyst Decision
  • RAPT Buy
  • EP
  • Analyst Count
  • RAPT 5
  • EP 0
  • Target Price
  • RAPT $5.25
  • EP N/A
  • AVG Volume (30 Days)
  • RAPT 1.1M
  • EP 30.3K
  • Earning Date
  • RAPT 05-08-2025
  • EP 05-14-2025
  • Dividend Yield
  • RAPT N/A
  • EP N/A
  • EPS Growth
  • RAPT N/A
  • EP N/A
  • EPS
  • RAPT N/A
  • EP N/A
  • Revenue
  • RAPT N/A
  • EP $42,796,178.00
  • Revenue This Year
  • RAPT N/A
  • EP N/A
  • Revenue Next Year
  • RAPT N/A
  • EP N/A
  • P/E Ratio
  • RAPT N/A
  • EP N/A
  • Revenue Growth
  • RAPT N/A
  • EP 6.28
  • 52 Week Low
  • RAPT $0.71
  • EP $3.76
  • 52 Week High
  • RAPT $4.60
  • EP $8.12
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 50.79
  • EP 57.73
  • Support Level
  • RAPT $0.86
  • EP $3.95
  • Resistance Level
  • RAPT $1.27
  • EP $4.14
  • Average True Range (ATR)
  • RAPT 0.13
  • EP 0.28
  • MACD
  • RAPT 0.01
  • EP 0.17
  • Stochastic Oscillator
  • RAPT 40.94
  • EP 68.03

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About EP Empire Petroleum Corporation

Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the US onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.

Share on Social Networks: